Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Quarterly results
|
|
Apyx Medical Corp (APYX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 08/15/2023 |
4
| Swandal Craig A. (Director) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 17,000 options to buy
@ $4.25, valued at
$72.3k
|
|
| 08/15/2023 |
4
| Baylor-Henry Minnie (Director) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 17,000 options to buy
@ $4.25, valued at
$72.3k
|
|
| 08/15/2023 |
4
| Levine Wendy Lauren (Director) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 17,000 options to buy
@ $4.25, valued at
$72.3k
|
|
| 08/15/2023 |
4
| Waldman Lawrence (Director) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 17,000 options to buy
@ $4.25, valued at
$72.3k
|
|
| 08/15/2023 |
4
| Geraghty Michael (Director) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 17,000 options to buy
@ $4.25, valued at
$72.3k
|
|
| 08/15/2023 |
4
| MAKRIDES ANDREW (Director) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 17,000 options to buy
@ $4.25, valued at
$72.3k
|
|
| 08/15/2023 |
4
| Andres John C. (Director) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 17,000 options to buy
@ $4.25, valued at
$72.3k
|
|
| 08/14/2023 |
SC 13G
| HIRSCHMAN ORIN reports a 5.4% stake in APYX MEDICAL CORPORATION |
| 08/10/2023 |
8-K
| Quarterly results |
| 07/19/2023 |
4
| Waldman Lawrence (Director) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Exercised 12,000 options to buy
@ $2.97, valued at
$35.6k
|
|
| 06/29/2023 |
4/A
| Hornsby Todd (Executive Vice President) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Sold 15,000 shares
@ $7.56, valued at
$113.4k
Exercised 15,000 options to buy
@ $1.77, valued at
$26.6k
|
|
| 06/09/2023 |
4
| Geraghty Michael (Director) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Exercised 10,000 options to buy
@ $2.79, valued at
$27.9k
|
|
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/19/2023 |
SC 13G
| Divisadero Street Capital Management, LP reports a 5.9% stake in Apyx Medical Corporation |
| 05/12/2023 |
SC 13G
| HIRSCHMAN ORIN reports a 5.8% stake in APYX MEDICAL CORPORATION |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 04/18/2023 |
8-K
| Quarterly results |
| 03/22/2023 |
4
| Swandal Craig A. (Director) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Exercised 7,173 options to buy
@ $9.42, valued at
$67.6k
|
|
| 03/16/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/16/2023 |
8-K
| Quarterly results |
| 03/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 02/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 6.6% stake in APYX MEDICAL CORPORATION |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/13/2023 |
4
| Hornsby Todd (Executive Vice President) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 100,000 options to buy
@ $2.5, valued at
$250k
|
|
| 01/13/2023 |
4
| CITRONOWICZ MOSHE (Sr. V.P. of Operations) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 72,000 options to buy
@ $2.5, valued at
$180k
|
|
| 01/13/2023 |
4
| Semb Tara (CFO) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 96,000 options to buy
@ $2.5, valued at
$240k
|
|
| 01/13/2023 |
4
| Goodwin Charles D. II (CEO) has filed a Form 4 on Apyx Medical Corp|
Txns:
| Granted 243,000 options to buy
@ $2.5, valued at
$607.5k
|
|
| 01/11/2023 |
SC 13G/A
| Cowen Financial Products LLC reports a 5.1% stake in Apyx Medical Corp. |
| 01/10/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 12/05/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/02/2022 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
|
|
|